Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8D8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,983
Award facts
- Contract value 100% obligated
- $13,982.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials with a ceiling value of $13,982.96. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a broad portfolio of medications and medical supplies. The company's contract awards demonstrate extensive experience fulfilling DLA Medical Supply Chain requirements for brand-name and generic pharmaceuticals, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The underlying IDC vehicle positions AmerisourceBergen to support military healthcare programs globally, with DLA planning additional regional Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple contractors in separate geographic areas.
Quick answers
Who was awarded contract SPE2DR26F8D8L?
SPE2DR26F8D8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F8D8L worth?
The government has obligated $13,983 on SPE2DR26F8D8L.
Is contract SPE2DR26F8D8L an order under another contract?
Yes. SPE2DR26F8D8L is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D8L competed?
The extent of competition for SPE2DR26F8D8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award